These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21991895)

  • 1. Clinical practice. Treating smokers in the health care setting.
    Fiore MC; Baker TB
    N Engl J Med; 2011 Sep; 365(13):1222-31. PubMed ID: 21991895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of varenicline in smoking cessation treatment.
    Aveyard P
    Thorax; 2008 Aug; 63(8):666-8. PubMed ID: 18663065
    [No Abstract]   [Full Text] [Related]  

  • 4. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation: how to advise the patient.
    Tonstad S
    Heart; 2009 Oct; 95(19):1635-40. PubMed ID: 19752210
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
    King DP; Paciga S; Pickering E; Benowitz NL; Bierut LJ; Conti DV; Kaprio J; Lerman C; Park PW
    Neuropsychopharmacology; 2012 Feb; 37(3):641-50. PubMed ID: 22048466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Sicras Mainar A; Navarro Artieda R; Díaz Cerezo S; Martí Sánchez B; Sanz De Burgoa V
    Aten Primaria; 2011 Sep; 43(9):482-9. PubMed ID: 21382649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    West R; Baker CL; Cappelleri JC; Bushmakin AG
    Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
    Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Kasza KA; Hyland AJ; Borland R; McNeill AD; Bansal-Travers M; Fix BV; Hammond D; Fong GT; Cummings KM
    Addiction; 2013 Jan; 108(1):193-202. PubMed ID: 22891869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing of smoking cessation medication in England since the introduction of varenicline.
    Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
    Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating smoking cessation into HIV care.
    Drach L; Holbert T; Maher J; Fox V; Schubert S; Saddler LC
    AIDS Patient Care STDS; 2010 Mar; 24(3):139-40. PubMed ID: 20214480
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
    Simon JA
    Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
    [No Abstract]   [Full Text] [Related]  

  • 19. Smoking cessation in pregnancy: why, how, and what next..
    Crawford JT; Tolosa JE; Goldenberg RL
    Clin Obstet Gynecol; 2008 Jun; 51(2):419-35. PubMed ID: 18463471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating tobacco dependence in a medical setting.
    Hurt RD; Ebbert JO; Hays JT; McFadden DD
    CA Cancer J Clin; 2009; 59(5):314-26. PubMed ID: 19706827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.